In the last several decades, a new diagnostic facet (the adverse drug and chemical reaction) has been added to the practice of pathology by the addition of a host of new chemical agents, not only into therapeutics, but also into the water, the air, the soil, and foods.
A measure of this tremendous increase in chemical agents i s found in the Drug Nomenclature Printout published by the Department of Drugs of the AMA. The most recent printout lists over thirty thousand names of over ten thousand agents.
Many of these therapeutic, diagnostic, prophylactic, and environmental agents are capable of producing adverse effects in both flora and fauna, and there are many investigators engaged in studying such adverse effects. To be of use in the total picture, their efforts must be communicated to others.
This leads me into one of the roles that the SPEP is playing: that of taking part in scientific COMMUNICATION!
We are COMMUNICATING here today, through this program devoted to the ENVIRONMENTAL AUTOPSY, which has been so ably set up by Dr. Gilbert E. Corrigan, of the University of Texas.
The complex chemical-pathologic problems of the current times are being studied by many specialists, each working in relatively narrow and deep areas. Integration of their efforts i s a necessity. It has been said that if all research were to be stopped, and the time and energies of scientists were devoted to correlating the mass of already accumulated information, that the answers to many unsolved problems would be a t hand-a putting of the twos and twos together.
Of course this would never happen. However, communication between the varidus scientists and scientific fields must be fostered; it is one of the objectives of the SPEP to take an active part in this transmission of scientific information in the fields of both pharmacologic and environmental pathology.
Today's meeting is not the first such effort of the SPEP. Last year we accepted the responsibility for a similar program a t the annual meeting of the American-Canadian Division of the International Academy of Pathology, in San Francisco, The theme of that meeting was ENVIRONMENTAL POLLUTANTS. Next month, we again participate as a society in the IAP meeting, in New Orleans, with a program on the theme of EXPERIMENTAL CARCINOGENESIS, under the co-chairmanship of Dr. Robert A. Squire and Dr. John Ferrell.
Our role in communication is further evidenced by an annual educational event carried out by one of our twelve committees, the Continuing Education Committee, under the chairmanship of Dr. Robert F. McConnell. Last June, in New Jersey, an all-day meeting on the subject of "Necropsy
Procedures Involving Laboratory Animals" was attended by 95 persons from 32 different institutions, coming from as far as California and Florida. This coming June, the subject of this annual conference will be "Hktotechnicrues" and will be expanded to a two-day program.
Other communication efforts of the SPEP include a quarterly Bulletin, a monthly Newsletter, and the holding of scientific meetings every two months throughout the year for its members in a variety of sites in the east coast area.
To mount this SPEP program, we have a membership consisting of representatives of over 100 organizations, composed of DVM's, VMD's, MD's, PhD's, and one DDS. Industry, academia, and various governmental agencies are represented in our membership, including the NIH, NCI, EPA, FDA, and the AFIP. I believe that this mixture of different interests, specialties, and affiliations i s one that itself w i l l foster this most important CURRENT need: COMMUNICATION.
One final point: I am impressed with the increasingly important and vital role that pathology i s playing in current health problems of both man and beast.
There has been, in recent years, an opinion voiced by some that the autopsy and much of morphologic pathology is dead, that developments in molecular biology are making such morphologic exercises unnecessary.
I think that we may be assured that the autopsy is indeed alive and well. The autopsy and biopsy are being utilized in the pre-marketing phases of drug development, and they are also continued into the marketing phase which i s the final testing ground for the capability of a drug or chemical to produce adverse effects. Such morphologic studies are also used in studying the effects on biologic organisms of the increasing numbers of environmental agents (both chemical and physical) of our technologic effluent, as witnessed by today's program on THE ENVIRONMENTAL AUTOPSY..
In closing, I want to thank Dr. Corrigan and the preceding fifteen speakers for their contributions to what I hope has been a successful effort in COMMUNICATION.
